SPAGO — Spago Nanomedical AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK35.29m
- SEK2.78m
- SEK0.44m
Brief: Spago Nanomedical Q2 Sales SEK 0
Brief: Spago Nanomedical Announces Outcome Of Rights Issue
Brief: Spago Nanomedical Resolves On Rights Issue Of About SEK 16 Million
Sweden's Spago Nanomedical Q1 loss narrows
Brief: Spago Nanomedical Q1 Sales SEK 22 Thousand
Brief: Spago Nanomedical Says Tumorad-01 Study Meets Primary Endpoint Of Maximum Tolerated Dose
Brief: Spago Nanomedical Continues Recruitment In Study
Sweden's Spago Nanomedical Q4 net sales plunge, loss narrows
Brief: Spago Nanomedical Q4 Sales SEK 4 Thousand
Brief: Spago Nanomedical Raises SEK 25 Million Through Rights Issue
Brief: Spago Nanomedical Q3 Sales SEK 14 Thousand
Brief: Spago Nanomedical Q2 Pre-tax Loss SEK 7 Mln
Brief: Spago Nanomedical Q2 Sales SEK 81 Thousand
Brief: Spago Nanomedical Q1 Sales SEK 338 Thousand
Brief: Spago Nanomedical Proposes Alan Raffensperger As New Chairman
Brief: Spago Nanomedical Q4 Sales SEK 617 Thousand
Brief: Spago Nanomedical Q3 Sales SEK 485 Thousand
Brief: Spago Nanomedical Focuses Resources On Development Of Tumorad
Brief: Spago Nanomedical: Phase I/IIa Study Tumorad-01 Continues